AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...
Modern AF systems are an exceptionally powerful and complex solution to a problem we don’t always have ...
“If any health care system tells you they’re perfect, it’s not a health care system you want,” Vice President F. Scott Ross said. “I don’t identify as a villain anymore and you’re not paying me enough ...
Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors.